Crocs, Inc. (NASDAQ:CROX) Shares Sold by Xponance Inc.

Xponance Inc. trimmed its stake in shares of Crocs, Inc. (NASDAQ:CROX) by 38.8% in the 2nd quarter, HoldingsChannel reports. The firm owned 8,470 shares of the textile maker’s stock after selling 5,366 shares during the period. Xponance Inc.’s holdings in Crocs were worth $1,236,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in CROX. Rise Advisors LLC acquired a new stake in shares of Crocs in the 1st quarter valued at $25,000. GHP Investment Advisors Inc. boosted its holdings in Crocs by 375.0% in the second quarter. GHP Investment Advisors Inc. now owns 228 shares of the textile maker’s stock valued at $33,000 after purchasing an additional 180 shares in the last quarter. Quest Partners LLC purchased a new position in Crocs in the fourth quarter valued at approximately $53,000. Blue Trust Inc. raised its holdings in Crocs by 19.3% during the second quarter. Blue Trust Inc. now owns 1,001 shares of the textile maker’s stock worth $144,000 after purchasing an additional 162 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its position in shares of Crocs by 8.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,041 shares of the textile maker’s stock worth $152,000 after buying an additional 85 shares during the last quarter. 93.44% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Barclays cut their price target on shares of Crocs from $169.00 to $164.00 and set an “overweight” rating on the stock in a research note on Friday, August 2nd. StockNews.com raised Crocs from a “hold” rating to a “buy” rating in a report on Friday, August 23rd. Piper Sandler restated an “overweight” rating and set a $170.00 price target on shares of Crocs in a research note on Friday, August 23rd. KeyCorp boosted their price objective on Crocs from $149.00 to $155.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, Raymond James lowered shares of Crocs from a “strong-buy” rating to an “outperform” rating and set a $164.00 target price on the stock. in a research report on Friday, August 2nd. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $160.82.

Crocs Stock Performance

NASDAQ:CROX opened at $144.31 on Friday. The firm has a market cap of $8.76 billion, a price-to-earnings ratio of 11.17, a price-to-earnings-growth ratio of 1.44 and a beta of 2.00. Crocs, Inc. has a 1-year low of $74.00 and a 1-year high of $165.32. The firm’s fifty day moving average price is $135.41 and its 200 day moving average price is $138.43. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.50 and a quick ratio of 0.95.

Crocs (NASDAQ:CROX) last issued its earnings results on Thursday, August 1st. The textile maker reported $4.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.59 by $0.42. Crocs had a return on equity of 53.20% and a net margin of 20.02%. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the business posted $3.59 EPS. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, sell-side analysts expect that Crocs, Inc. will post 12.85 EPS for the current year.

Insider Buying and Selling at Crocs

In other Crocs news, Director Douglas J. Treff sold 10,594 shares of the stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $132.38, for a total value of $1,402,433.72. Following the completion of the transaction, the director now directly owns 81,254 shares of the company’s stock, valued at $10,756,404.52. The sale was disclosed in a filing with the SEC, which is available at this link. In other Crocs news, Director Douglas J. Treff sold 10,594 shares of the firm’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the completion of the transaction, the director now directly owns 81,254 shares in the company, valued at approximately $10,756,404.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John B. Replogle purchased 1,996 shares of Crocs stock in a transaction on Friday, August 2nd. The stock was acquired at an average cost of $123.96 per share, for a total transaction of $247,424.16. Following the acquisition, the director now directly owns 7,064 shares of the company’s stock, valued at $875,653.44. The disclosure for this purchase can be found here. 2.72% of the stock is owned by corporate insiders.

About Crocs

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.